7 Growth Stocks to Buy With $1,000 or You’ll Be Kicking Yourself in 2025

In This Article:

The broader market rally has left many investors wondering if there are any growth stocks to buy before a correction. I believe that there absolutely are. Despite the run-up, a number of high-potential growth stocks remain undervalued. Their fundamentals have only gotten stronger.

I believe these stocks are poised for a major bounce-back over the next 12 months. Several have already begun to recover. Now may be the time to establish a position before they really take off.

Investing just $1,000 across these picks could generate market-beating returns. A few even have the potential to become multi-baggers. That means a relatively small investment today might lead to very sizable gains.

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Here are seven to look into:

Bombardier (BDRBF)

BOMBARDIER sign is seen during the 12th China International Aviation and Aerospace Exhibition, also known as Airshow China 2018. BDRBD stock

Source: testing / Shutterstock.com

Bombardier (OTCMKTS:BDRBF) designs and manufactures business jets for corporations, governments, and wealthy individuals. The Canadian aerospace company has been on a roll lately, with its stock price surging over 78% so far in 2024. I believe Bombardier is well-positioned to benefit from the ongoing boom in private aviation and increased defense spending.

In the first quarter, Bombardier grew its order backlog to $14.9 billion. The company also expanded margins and is on track to deliver 150-155 aircraft this year, up from 138 in 2023. Bombardier’s high-margin aftermarket service revenues jumped 13% year-over-year in Q1.

Analysts are quite bullish on the stock, with 8 out of 11 rating it a “Buy.” I personally believe that this stock could cross $100.

Last week, Bombardier reached a new 3-year labor deal with its union, ending an 18-day strike. The company is also doing its part for the environment, installing thousands of solar panels to slash emissions at its London service center. Thus, the company looks poised to hit its 2025 targets of $9 billion in revenue and $1.6 billion in EBITDA, making it among the best growth stocks to buy.

Paysign (PAYS)

An image of two cellphones with coins flying from one screen into the other. Fintech Growth Stocks

Source: kentoh/Shutterstock

Paysign (NASDAQ:PAYS) is a leading provider of prepaid card programs and integrated payment processing solutions. The company has been making waves lately with impressive financial results and a promising growth trajectory. In the first quarter of 2024, Paysign’s revenue surged 30% year-over-year to $13.2 million, beating analyst estimates. Net income turned positive at $309,000, a significant improvement from the net loss in the same period last year.

I believe Paysign is well-positioned to capitalize on the megatrend of digital payments and the tailwinds of increasing healthcare spending. The company’s focus on the healthcare industry, particularly its rapidly expanding patient affordability business, sets it apart. It has a pipeline of new programs and partnerships with major pharmaceutical companies. As such, I’m not surprised to see that Paysign’s patient affordability revenue skyrocketed by 305% in Q1 2024.